Pharmacogenomics is being implemented now and is already have an impact in the clinical setting and in healthcare. Employing a pharmacogenomics strategy with marketed drugs can mitigate risk by avoiding adverse events, allowing the identification of patients most likely to benefit from a drug, and thereby improving patient compliance and safety. Tangible benefits of pharmacogenomics and resequencing technologies will be presented, and the value of this approach will be demonstrated.
CHI鈥橲 Pharmacogenomics Now: Maximizing Benefits/Minimizing Risk
5 - 6 November 2008, Montreal, Quebec, Canada
Introduction
Venue
Hotel Omni Mont-Royal
Hotel Omni Mont-Royal, Montreal, Quebec, Canada
Useful links
Organised by
Cambridge Healthtech Institute
Contact information
Related events
Advancements in prosthetic/artificial heart valve devices
25 February 2025 17:00-18:30, United Kingdom
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
TAC 2025 - 60th Anniversary Conference
14 April 2025 09:00 - 16 April 2025 17:00, Guildford, United Kingdom
麻豆AV Energy Sector Next Generation Materials for Solar Photovoltaics 2025
16 January 2025, London, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
